The Future of Genome Sequencing is Here: Introducing PacBio Revio

PacBio releases Revio, a long-read gene sequencing system

October 26, 2022

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announces Revio™, a long-read sequencing system that enables customers to dramatically scale their use of PacBio’s celebrated HiFi sequencing technology. Revio is designed to provide customers with the ability to sequence up to 1,300 human whole genomes per year for less than $1,000 per genome. With this scale and pricing, PacBio is poised to provide HiFi sequencing to large studies in human genetics, cancer research, agricultural genomics, and more.

PacBio Revio

Whipsaw partnered with PacBio to identify an all-new user interaction model and to design a stunning new industrial design for the instrument, including an intuitive user interface. The design improvements maximize sample throughput by enabling users to set up back-to-back runs, manage instruments remotely and monitor progress at-a-glance. The Revio system will require 50 percent fewer consumables, thanks to a consolidation of reagents and sample plates into a single unit.

Revio’s bold and architectural design language communicates sophistication, competence, and precision, which is exactly what their brand and technology offers. Every design detail has been optimized, including a perfectly flush sliding glass door with an integrated display, a sports car inspired woven wire ventilation grill, tasteful and intuitive physical and digital controls, and a very unique color application of three shades of gray which help to break up the boxy proportions.

Learn more at

Share this article